IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $506,000 | +226.5% | 82,830 | +242.2% | 0.00% | +100.0% |
| Q4 2022 | $155,000 | -45.6% | 24,206 | -18.5% | 0.00% | 0.0% |
| Q3 2022 | $285,000 | -77.9% | 29,700 | -61.7% | 0.00% | -80.0% |
| Q1 2022 | $1,290,000 | -15.8% | 77,463 | -3.5% | 0.01% | 0.0% |
| Q4 2021 | $1,532,000 | -24.5% | 80,249 | -2.4% | 0.01% | -28.6% |
| Q3 2021 | $2,028,000 | -6.0% | 82,220 | -0.8% | 0.01% | -12.5% |
| Q2 2021 | $2,157,000 | -6.9% | 82,887 | +13.3% | 0.01% | -11.1% |
| Q1 2021 | $2,317,000 | -26.2% | 73,175 | +8.1% | 0.01% | -35.7% |
| Q4 2020 | $3,141,000 | +74.5% | 67,700 | +23.8% | 0.01% | +40.0% |
| Q3 2020 | $1,800,000 | +27.1% | 54,673 | +6.0% | 0.01% | +25.0% |
| Q2 2020 | $1,416,000 | – | 51,590 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |